Retisert

RETISERT (fluocinolone acetonide intravitreal implant) 0.59 mg is a sterile implant designed to release fluocinolone acetonide locally to the posterior segment of the eye at a nominal initial rate of 0.6 μg/day, decreasing over the first month to a steady state between 0.3 to 0.4 μg/day over approximately 30 months.

Indication and Usage
RETISERT (fluocinolone acetonide intravitreal implant) 0.59 mg is a corticosteroid indicated for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye.

In patients with chronic non-infectious posterior uveitis RETISERT is designed to deliver corticosteroid therapy for approximately 2.5 years precisely where it’s needed.

Reviews

There are no reviews yet.

Be the first to review “Retisert”